Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis
G. Simmons, N. Jones, and L. Calder. The Journal of Antimicrobial Chemotherapy, 45 (6):
909--11(June 2000)PMID: 10837450.
Abstract
The efficacy of ceftriaxone in eliminating nasopharyngeal carriage of Neisseria meningitidis was compared with that of rifampicin during an epidemic of serogroup B meningococcal disease in Auckland, New Zealand. Household contacts of cases had a throat swab taken and were randomized to treatment. Carriers had a repeat swab taken 6 days later to determine efficacy of treatment. Ceftriaxone (98.2\%) was equivalent to rifampicin (97.6\%) in eliminating serogroup B N. meningitidis. It is cheaper than rifampicin and has the advantage of full compliance and fewer contraindications, but its acceptability by patients may limit its use as a first-line prophylactic agent.
%0 Journal Article
%1 simmons_equivalence_2000
%A Simmons, G
%A Jones, N
%A Calder, L
%D 2000
%J The Journal of Antimicrobial Chemotherapy
%K Adolescent, Adult, Antibiotics, Antitubercular, Carrier Ceftriaxone, Cephalosporins, Child, Humans, Infant, Infections, Meningococcal Nasopharynx, Neisseria Newborn, Preschool, Rifampin, Serotyping State, meningitidis,
%N 6
%P 909--11
%T Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis
%U http://www.ncbi.nlm.nih.gov/pubmed/10837450
%V 45
%X The efficacy of ceftriaxone in eliminating nasopharyngeal carriage of Neisseria meningitidis was compared with that of rifampicin during an epidemic of serogroup B meningococcal disease in Auckland, New Zealand. Household contacts of cases had a throat swab taken and were randomized to treatment. Carriers had a repeat swab taken 6 days later to determine efficacy of treatment. Ceftriaxone (98.2\%) was equivalent to rifampicin (97.6\%) in eliminating serogroup B N. meningitidis. It is cheaper than rifampicin and has the advantage of full compliance and fewer contraindications, but its acceptability by patients may limit its use as a first-line prophylactic agent.
@article{simmons_equivalence_2000,
abstract = {The efficacy of ceftriaxone in eliminating nasopharyngeal carriage of Neisseria meningitidis was compared with that of rifampicin during an epidemic of serogroup B meningococcal disease in Auckland, New Zealand. Household contacts of cases had a throat swab taken and were randomized to treatment. Carriers had a repeat swab taken 6 days later to determine efficacy of treatment. Ceftriaxone (98.2\%) was equivalent to rifampicin (97.6\%) in eliminating serogroup B N. meningitidis. It is cheaper than rifampicin and has the advantage of full compliance and fewer contraindications, but its acceptability by patients may limit its use as a first-line prophylactic agent.},
added-at = {2011-03-11T10:05:34.000+0100},
author = {Simmons, G and Jones, N and Calder, L},
biburl = {https://www.bibsonomy.org/bibtex/2033012ef113f9db2c2e3d6d728ad3e0d/jelias},
interhash = {62acaaed7a56811d8a0a879fe4d25686},
intrahash = {033012ef113f9db2c2e3d6d728ad3e0d},
issn = {0305-7453},
journal = {The Journal of Antimicrobial Chemotherapy},
keywords = {Adolescent, Adult, Antibiotics, Antitubercular, Carrier Ceftriaxone, Cephalosporins, Child, Humans, Infant, Infections, Meningococcal Nasopharynx, Neisseria Newborn, Preschool, Rifampin, Serotyping State, meningitidis,},
month = jun,
note = {{PMID:} 10837450},
number = 6,
pages = {909--11},
timestamp = {2011-03-11T10:06:21.000+0100},
title = {Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis},
url = {http://www.ncbi.nlm.nih.gov/pubmed/10837450},
volume = 45,
year = 2000
}